Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era

Journal of Urology

Volumn 195, Issue 4, 2016, Pages 913-918

  Sammon, Jesse D ^a,b,d,e   Dalela, Deepansh ^e   Abdollah, Firas ^e   Choueiri, Toni K ^c   Han, Paul K ^b,d   Hansen, Moritz ^b,d   Nguyen, Paul L ^c   Sood, Akshay ^e   Menon, Mani ^e   Trinh, Quoc Dien ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Maine Medical Center Research Institute   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

African American; education; mass screening; prostate; prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BLACK PERSON; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; HEALTH CARE ACCESS; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; INCOME; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; PRIORITY JOURNAL; RACE DIFFERENCE; SELF REPORT; UNITED STATES; URBAN AREA; AFRICAN AMERICAN; CAUCASIAN; EARLY CANCER DIAGNOSIS; ETHNOLOGY; PROCEDURES; PROSTATE TUMOR; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SELF REPORT; UNITED STATES;

EID: 84964521159     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.11.023     Document Type: Article

References (29)

1. Greene, K.L., Albertsen, P.C., Babaian, R.J., et al. Prostate specific antigen best practice statement: 2009 update. J Urol, 182, 2009, 2232.
2. Lim, L.S., Sherin, K., Screening for prostate cancer in U.S. men. ACPM position statement on preventive practice. Am J Prev Med, 34, 2008, 164.
3. Wolf, A.M., Wender, R.C., Etzioni, R.B., et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin, 60, 2010, 70.
4. Moyer, V.A., Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 157, 2012, 120.
5. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J Clin, 65, 2015, 5.
6. Powell, I.J., Vigneau, F.D., Bock, C.H., et al. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men. Cancer Epidemiol Biomarkers Prev, 23, 2014, 1505.
7. Tangen, C.M., Hussain, M.H., Higano, C.S., et al. Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). J Urol, 188, 2012, 1164.
8. Andriole, G.L., Crawford, E.D., Grubb, R.L. 3rd, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst, 104, 2012, 125.
9. Schröder, F.H., Hugosson, J., Roobol, M.J., et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med, 366, 2012, 981.
10. Knight, S.J., Decision making and prostate cancer screening. Urol Clin North Am, 41, 2014, 257.
11. Hoffman, R.M., Couper, M.P., Zikmund-Fisher, B.J., et al. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). Arch Intern Med, 169, 2009, 1611.
12. Pollack, C.E., Platz, E.A., Bhavsar, N.A., et al. Primary care providers' perspectives on discontinuing prostate cancer screening. Cancer, 118, 2012, 5518.
13. Carpenter, W.R., Howard, D.L., Taylor, Y.J., et al. Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes Control, 21, 2010, 1071.
14. Ross, L.E., Berkowitz, Z., Ekwueme, D.U., Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev, 17, 2008, 636.
15. Pucheril, D., Sammon, J., Sood, A., et al. Contemporary nationwide patterns of self-reported prostate-specific antigen screening in United States veterans. Urol Oncol, 33, 2015, 503.e7.
16. Saltzman, A.F., Luo, S., Scherrer, J.F., et al. Earlier prostate-specific antigen testing in African American men—clinical support for the recommendation. Urol Oncol, 33, 2015, 330.e9.
17. Haque, R., Van Den Eeden, S.K., Jacobsen, S.J., et al. Correlates of prostate-specific antigen testing in a large multiethnic cohort. Am J Manag Care, 15, 2009, 793.
18. Bloom, J.R., Stewart, S.L., Oakley Girvan, I., et al. Family history, perceived risk, and prostate cancer screening among African American men. Cancer Epidemiol Biomarkers Prev, 15, 2006, 2167.
19. Tingen, M.S., Weinrich, S.P., Heydt, D.D., et al. Perceived benefits: a predictor of participation in prostate cancer screening. Cancer Nurs, 21, 1998, 349.
20. Pucheril, D., Dalela, D., Sammon, J., et al. The influence of physician recommendation on prostate-specific antigen screening. Urol Oncol, 33, 2015, 424.e1.
21. Sammon, J.D., Pucheril, D., Diaz, M., et al. Contemporary nationwide patterns of self-reported prostate-specific antigen screening. JAMA Intern Med, 174, 2014, 1839.
22. Hudson, M.A., Luo, S., Chrusciel, T., et al. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?. Urol Oncol, 32, 2014, 34.e9.
23. Burki, T., Cancer and cultural differences. Lancet Oncol, 11, 2010, 1125.
24. Paradies, Y., Truong, M., Priest, N., A systematic review of the extent and measurement of healthcare provider racism. J Gen Intern Med, 29, 2014, 364.
25. Drazer, M.W., Prasad, S.M., Huo, D., et al. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer, 120, 2014, 1491.
26. Prasad, S.M., Drazer, M.W., Huo, D., et al. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. JAMA, 307, 2012, 1692.
27. Schaeffer, E.M., Carter, H.B., Kettermann, A., et al. Prostate specific antigen testing among the elderly—when to stop?. J Urol, 181, 2009, 1606.
28. Han, P.K., Kobrin, S., Breen, N., et al. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med, 11, 2013, 306.
29. Bhan, N., Kawachi, I., Glymour, M.M., et al. Time trends in racial and ethnic disparities in asthma prevalence in the united states from the Behavioral Risk Factor Surveillance System (BRFSS) study (1999-2011). Am J Public Health, 105, 2015, 1269.